Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
+4.11M
-
Total reported value, excl. options
-
$8.13B
-
Value change
-
+$544M
-
Put/Call ratio
-
0.97
-
Number of buys
-
129
-
Number of sells
-
-138
-
Price
-
$111.31
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2020
348 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2020.
NovoCure Ltd - Common Stock (NVCR) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
of 112M outstanding shares and own 65.21% of the company stock.
Largest 10 shareholders include FMR LLC (9.96M shares), VANGUARD GROUP INC (8.21M shares), Capital International Investors (8.2M shares), BAILLIE GIFFORD & CO (8.12M shares), Capital World Investors (6.63M shares), BlackRock Inc. (5.98M shares), CREDIT SUISSE AG/ (1.65M shares), MACQUARIE GROUP LTD (1.51M shares), Darsana Capital Partners LP (1.33M shares), and MORGAN STANLEY (1.32M shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.